BGM Group Warned by Nasdaq for Late Annual Report Filing
BGM Group announced that it has received a notification from Nasdaq regarding its non-compliance with the Nasdaq Listing Rule 5250 as a result of the company's failure to file its annual report on Form 20-F for the fiscal year ended September 30, 2025 in a timely manner.
Trade with 70% Backtested Accuracy
Analyst Views on BGM
About BGM
About the author
Toro, DBV Technologies, Udemy, ABM Industries, and Other Major Stocks Rising on Wednesday
U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Dow Jones gaining over 150 points, while several companies, including Toro Co, reported better-than-expected quarterly earnings, leading to significant stock price increases.
Notable Stock Gains: Toro Co's shares rose 7% after reporting earnings of 91 cents per share, while DBV Technologies saw a 35.5% increase following positive trial results. Other companies like Udemy and Kodiak Sciences also experienced substantial gains.
Sector Highlights: Cannabis-related stocks surged after reports of potential reclassification of marijuana, with Canopy Growth Corp gaining 16.2%. Lithium-related stocks also rose following the cancellation of mining permits in Yichun.
Company Announcements and Upgrades: Several companies, including Recursion Pharmaceuticals and Two Harbors Investment Corp, saw stock price increases due to upgrades and acquisition announcements, reflecting positive investor sentiment.
Major Stocks Including Freeport-McMoRan, Harmony Biosciences, and Cohu Decline on Wednesday
U.S. Stock Market Performance: U.S. stocks declined, with the Dow Jones index dropping over 150 points, influenced by significant losses in various companies, particularly Freeport-McMoRan, which fell 16.4% after issuing disappointing sales guidance and reporting fatalities at its mine.
Notable Stock Declines: Other companies also experienced substantial losses, including Zhengye Biotechnology (-28.2%), Harmony Biosciences (-14.6%), and Cohu, Inc. (-12.7%), with Harmony's decline attributed to unmet clinical trial expectations and a lowered price target from Needham.
Major Stocks Including Lyft, Oruka Therapeutics, Roivant Sciences, and Workday Rise on Wednesday
U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Dow Jones gaining over 200 points, while Lyft's shares surged 13.5% following a partnership with Waymo to manage autonomous vehicles in Nashville.
Notable Stock Gains: Several companies experienced significant stock increases, including New Fortress Energy (up 32.3%), Oruka Therapeutics (up 14.1%), and Workday (up 9%) after positive announcements and upgrades.
BGM To Report First Half 2025 Unaudited Financial Results on July 24, 2025
Financial Results Announcement: BGM Group will release its unaudited financial results for the first half of 2025 on July 24, 2025, before U.S. markets open.
Company Overview: BGM Group focuses on AI applications, intelligent robotics, algorithmic computing, cloud computing, and biopharmaceuticals, integrating AI into their production processes to enhance efficiency and provide customized services in various sectors.
From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts
Acquisition Announcement: BGM Group Ltd. has entered into agreements to acquire 100% equity interests in Xingdao Intelligent Cloud Chain and YD Network for a combined valuation of RMB800 million, expected to close by the end of June 2025.
Strategic Expansion: The acquisitions aim to enhance BGM's AI capabilities in both robotics and fintech, allowing for deeper integration of hardware and software, and expanding its multi-agent AI productivity platform across various industries.
D-Wave Quantum And Advance Auto Parts Are Among Top 7 Mid-Cap Gainers Last Week (May 19-May 23): Are The Others In Your Portfolio?
Top Performing Mid-Cap Stocks: D-Wave Quantum Inc. saw a 53.47% increase after launching its Advantage2 quantum system, while Regencell Bioscience Holdings and Advance Auto Parts also experienced significant gains of 42.49% and 38.94%, respectively, following positive company announcements.
Other Notable Stock Increases: Merus N.V. rose by 32.68% due to promising clinical trial data, Oklo Inc. gained 29.56% amid regulatory easing reports, and several other mid-cap stocks like Sibanye-Stillwater Limited and BGM Group Ltd. also showed strong performance last week.
Toro, DBV Technologies, Udemy, ABM Industries, and Other Major Stocks Rising on Wednesday
U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Dow Jones gaining over 150 points, while several companies, including Toro Co, reported better-than-expected quarterly earnings, leading to significant stock price increases.
Notable Stock Gains: Toro Co's shares rose 7% after reporting earnings of 91 cents per share, while DBV Technologies saw a 35.5% increase following positive trial results. Other companies like Udemy and Kodiak Sciences also experienced substantial gains.
Sector Highlights: Cannabis-related stocks surged after reports of potential reclassification of marijuana, with Canopy Growth Corp gaining 16.2%. Lithium-related stocks also rose following the cancellation of mining permits in Yichun.
Company Announcements and Upgrades: Several companies, including Recursion Pharmaceuticals and Two Harbors Investment Corp, saw stock price increases due to upgrades and acquisition announcements, reflecting positive investor sentiment.
Major Stocks Including Freeport-McMoRan, Harmony Biosciences, and Cohu Decline on Wednesday
U.S. Stock Market Performance: U.S. stocks declined, with the Dow Jones index dropping over 150 points, influenced by significant losses in various companies, particularly Freeport-McMoRan, which fell 16.4% after issuing disappointing sales guidance and reporting fatalities at its mine.
Notable Stock Declines: Other companies also experienced substantial losses, including Zhengye Biotechnology (-28.2%), Harmony Biosciences (-14.6%), and Cohu, Inc. (-12.7%), with Harmony's decline attributed to unmet clinical trial expectations and a lowered price target from Needham.
Major Stocks Including Lyft, Oruka Therapeutics, Roivant Sciences, and Workday Rise on Wednesday
U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Dow Jones gaining over 200 points, while Lyft's shares surged 13.5% following a partnership with Waymo to manage autonomous vehicles in Nashville.
Notable Stock Gains: Several companies experienced significant stock increases, including New Fortress Energy (up 32.3%), Oruka Therapeutics (up 14.1%), and Workday (up 9%) after positive announcements and upgrades.
BGM To Report First Half 2025 Unaudited Financial Results on July 24, 2025
Financial Results Announcement: BGM Group will release its unaudited financial results for the first half of 2025 on July 24, 2025, before U.S. markets open.
Company Overview: BGM Group focuses on AI applications, intelligent robotics, algorithmic computing, cloud computing, and biopharmaceuticals, integrating AI into their production processes to enhance efficiency and provide customized services in various sectors.
From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts
Acquisition Announcement: BGM Group Ltd. has entered into agreements to acquire 100% equity interests in Xingdao Intelligent Cloud Chain and YD Network for a combined valuation of RMB800 million, expected to close by the end of June 2025.
Strategic Expansion: The acquisitions aim to enhance BGM's AI capabilities in both robotics and fintech, allowing for deeper integration of hardware and software, and expanding its multi-agent AI productivity platform across various industries.
D-Wave Quantum And Advance Auto Parts Are Among Top 7 Mid-Cap Gainers Last Week (May 19-May 23): Are The Others In Your Portfolio?
Top Performing Mid-Cap Stocks: D-Wave Quantum Inc. saw a 53.47% increase after launching its Advantage2 quantum system, while Regencell Bioscience Holdings and Advance Auto Parts also experienced significant gains of 42.49% and 38.94%, respectively, following positive company announcements.
Other Notable Stock Increases: Merus N.V. rose by 32.68% due to promising clinical trial data, Oklo Inc. gained 29.56% amid regulatory easing reports, and several other mid-cap stocks like Sibanye-Stillwater Limited and BGM Group Ltd. also showed strong performance last week.
